Uncategorized
Regulators tune the Volcker rule
admin | January 31, 2020
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.
Small changes can make a big difference when it comes to the way banks manage their current $13.8 trillion in assets. And regulators in the last few days have recommended some small changes in the Volcker rule governing bank investment in debt and credit funds. The market in CLOs and leveraged credit seems the clearest potential beneficiary, although other corners of the capital markets could see new bank interest, too.
Constraints on CLOs
Even though banks currently hold around $90 billion in CLOs mainly in ‘AAA’ classes, regulations have sometimes clouded banks’ ability to invest. The Volcker rule intended to eliminate bank investment in funds that could put insured deposits at risk but excluded loan securitizations from that list of funds. The rule has led CLOs to hold only leveraged loans and exclude high yield debt. It has also ruled out CLO participation in debt restructurings that might exchange loans for equity or related instruments—limiting CLOs ability to manage distressed credits.
Volcker also stops banks from holding ownership interests in funds, which some regulators interpret broadly to include debt interests with the right fire a manager for cause. Most ‘AAA’ CLOs have this right, although banks have differed in their willingness risk an interpretation that ‘AAA’ CLOs violate Volcker.
Litigation has also challenged bank holdings of CLOs. A suit pending against JP Morgan, Kirschner v. JP Morgan et al., argues that the term loans usually held by CLOs fall under federal securities laws and do not qualify for the Volcker allowance for loan securitizations. If that suit were decided against JP Morgan, banks potentially would need to sell their current CLO holdings.
Addressed by the latest proposed changes
Some of the key provisions of the Fed’s latest proposal address constraints around CLOs as well as potentially expanding bank investment in other types of debt funds, business development companies and the like (Exhibit 1). The proposed changes would allow banks to invest in funds with up to 5% of assets in non-loan instruments, opening the door to holdings of high yield debt, equity, warrants and other instruments. The proposal also specifies that funds could hold a limited amount of equity associated with loans or debt, which seems targeted to allowing funds to participate in debt restructurings. The proposal specifies that the ability of a debt holder to fire a manager for cause would not constitute an ownership interest. And the proposal creates a safe harbor from litigation like Kirschner v. JP Morgan, laying out criteria that most CLO loans and high yield debt would be able to meet.
Other areas, too
Banks could become more invested in business development companies under the proposed changes, getting more exposure to the middle market loans usually owned by those investors. And banks could invest in securitizations that included mortgage servicing and leases.
Most of these changes seem reasonable clarifications of grey areas in the Volcker rule. Banks sidelined by earlier uncertainty around the rule seem likely to take a new look at a range of assets, especially CLOs and especially in a market where yield is increasingly hard to find.
Exhibit 1: A summary of key Fed proposed modifications to the Volcker rule
Source: Federal Reserve Board, Amherst Pierpont Securities
***
The view in rates
The sharp drop in rates over the last two weeks seems equal parts fact and fear, and fear seems to be winning. The fact part highlights the growth in China’s share of global GDP since the SARS outbreak in 2003: around 4% then, around 19% now. So it is true that the current quarantines in China, the restrictions on travel and the like have almost certainly hurt China’s GDP. Of course, it is likely that pent up demand would resurface once there’s clarity on the coronavirus and GDP would partially or fully catch up. The fear part revolves around scenarios that hint of pandemic. At this point, the coronavirus seems roughly as contagious as SARS but much less fatal, and estimated time to a tested and approved vaccine ranges from a year or more. Given the emerging scientific and public health collaboration to address the outbreak, it seems likely that the uncertainty around the outbreak will fall quickly. As it falls, rates should rise.
The view in spreads
The appetite for spread and compounding income is still strong, but investors have clearly stepped back to watch the coronavirus play out. It seems reasonable. After all, it’s a risk that’s undoubtedly hard to price. Still, the US economy looks healthy enough to keep credit concerns at bay for investment grade companies and even most high yield companies, so spreads have room to compress further once uncertainty around the virus drops. MBS has some room to run tighter even though low rates stand to keep prepayments elevated through the spring, especially in Ginnie Mae MBS. If the economy moves above current expectations of less than 2% real GDP growth, spreads should tighten further.
The view in credit
A variety of measures of corporate leverage remain high, but leverage spells trouble only if growth falls below current expectations and financing for leveraged borrowers tightens. That does not look likely. It looks more likely growth might slightly exceed expectations, lifting corporate fundaments. As for the consumer, that is a story of generally continued strength with low unemployment, strong income, rising net worth and low debt service as a share of income.
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Important Disclaimers
Copyright © 2025 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.
Important disclaimers for clients in the EU and UK
This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).
The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.
This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.
This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.
This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.
